top of page


FDA clears PrecivityAD2 Alzheimer’s blood test for symptomatic adults aged 40 and older
The clearance extends FDA-authorised blood-based assessment of Alzheimer’s-associated amyloid pathology to younger symptomatic adults, providing clinicians with a less invasive alternative to PET imaging and cerebrospinal fluid testing.

nuaxia
2 days ago2 min read


FDA approves SimpleScreen™ CRC blood test for colorectal cancer screening in average-risk adults
The approval provides adults aged 45 years and older at average risk of colorectal cancer with an additional blood-based screening option, expanding access for individuals who are overdue for screening.

nuaxia
Jul 292 min read


FDA Clears iHealthScreen’s AI Diabetic Retinopathy Screening Software
iPredict-DR uses artificial intelligence to analyse retinal images and support earlier detection of diabetic eye disease.

nuaxia
Jul 133 min read


FDA Clears AI-Powered Diabetic Retinopathy Screening Software from iHealthScreen
The AI-powered software analyses retinal images captured by the widely used iCare DRSplus camera, supporting earlier detection of diabetic retinopathy in primary care and community healthcare settings.

nuaxia
Jul 103 min read
bottom of page